# Dianthus Therapeutics, Inc.: Form 8-K, filed Nov 19, 2018

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2018-11-19
- Accepted by EDGAR: Nov 19, 2018, 16:10 ET
- Period: 2018-11-19
- Accession: 0001193125-18-330256
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312518330256/d655434d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312518330256/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312518330256/d655434d8k.htm

Filed Nov 19, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-330256. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.